NexgenRx Announces Q2 2018 Results

About this update from Nexgenrx Inc.

[{"type":"text","content":"NexgenRx Announces Q2 2018 Results \n\t\t\tbody { font-size: 11pt;\n\t\t\t}\n\n\t\t\t.nr-sub-head ul,\n\t\t\t.nr-body ul {\n\t\t\t\tlist-style-type: disc !important;\n\t\t\t\tmargin-left: 2em !important;\n\t\t\t}\n\n\t\t\t.nr-sub-head ol,\n\t\t\t.nr-body ol {\n\t\t\t\tmargin-left: 2em !important;\n\t\t\t}\n\n\t\t\t.nr-body p, .nr-body {margin-bottom: 0px !important;\n\t\t\t\t\tmargin-top: 0px !important;\n\t\t\t\t\t-webkit-margin-before: 0px !important;\n\t\t\t\t\t-webkit-margin-after: 0px !important;\n\t\t\t\t\tfont-family: Arial !important;\n\t\t\t\t\tfont-size: 11pt !important;\n\t\t\t }\n\n\t\t\ttbody {\n\t\t\t\tborder-top: 0;\n\t\t\t}\n\n\t\t\t H1 {font-weight: bold;\n\t\t\t\tfont-size: 16pt;\n\t\t\t }\n\n\t\t\t H2 {font-weight: bold;\n\t\t\t\tfont-size: 12pt;\n\t\t\t }\n\n\t\t\t H3 {font-weight: bold;\n\t\t\t\tfont-size: 11pt;\n\t\t\t }\n\n\n\t\t\t H1.nr-head {\n\t\t\t \t\tfont-family: Trebuchet MS !important;\n\t\t\t \t\tfont-size: 16pt !important;\n\t\t\t \t\tcolor: #3D86C6 !important;\n\t\t\t \t\tfont-weight:bold !important;\n\t\t\t \t\ttext-align:center !important;\n\n\t\t\t }\n\n\t\t\t H2.nr-sub-head {font-weight: bold !important;\n\t\t\t \t\tdisplay: block !important;\n\t\t\t \t\ttext-align: start !important;\n\t\t\t \t\tfont-family: Arial !important;\n\t\t\t\t\tfont-size: 12pt !important;\n\t\t\t }\n\n\t\t\t .nr-body a { font-size: 11pt !important;\n\t\t\t }\n\n\t\t\t TABLE { width: auto!important;\n\t\t\t }\n\n\t\t NexgenRx Announces Q2 2018 Results\n Toronto, Ontario (FSCwire) - NEXGENRX INC. (\"NexgenRx\" or the \"Company\") is pleased to announce its Q2 2018 financial results.\n\n \n\nRevenue during Q2 2018 grew slightly over the same three month period last year. Revenue for the second quarter was $1,464,698 and $3,010,256 year-to-date, representing a 2.3% increase. While new client revenue growth has been softer than expected, the Company anticipates its sales efforts will be rewarded over the next several quarters.  First and second 2018 quarter expenses are essentially flat, as expected and as previously communicated, but up 15% on a year-over-year quarterly basis.\n\n \n\nThe Company was active in the second quarter, performing its due diligence to acquire two benefit administration companies, Canadian Benefit Administrators Ltd. (\"CBA\") and My Benetech Inc. (\"MBT\"), which culminated in t...

More updates from Nexgenrx Inc.